HighVista Strategies’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
HighVista Strategies's IMVT Position: Q3 2026 in Review
HighVista Strategies reduced its Immunovant (IMVT) stake by 26% in Q3 2026, selling an estimated $2.83M and leaving 205,954 shares worth $6.96M. The position accounts for 1.83% of the portfolio, ranked #9.
HighVista Strategies first reported a position in IMVT in Q3 2020 and has held it in 13 quarters since. The position peaked at $10.7M in Q2 2026. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- HighVista Strategies held 205,954 shares of Immunovant worth $6.96M as of Q3 2026.
- HighVista Strategies sold 71,919 Immunovant shares in Q3 2026, an estimated $2.83M.
- Immunovant made up 1.83% of HighVista Strategies's portfolio in Q3 2026, its #9 holding.
- HighVista Strategies first reported a position in Immunovant in Q3 2020 and has held it in 13 quarters since.
- HighVista Strategies's Immunovant position peaked at $10.7M in Q2 2026.
- 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on HighVista Strategies's 13F filing for Q3 2026, filed 13 Nov 2026.